<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.1d1" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher">Problems of Social Hygiene, Public Health and History of Medicine</journal-id><journal-title-group><journal-title>Problems of Social Hygiene, Public Health and History of Medicine</journal-title></journal-title-group><issn publication-format="print">0869-866X</issn><issn publication-format="electronic">2412-2106</issn><publisher><publisher-name>Joint-Stock Company Chicot</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1057</article-id><article-id pub-id-type="doi">10.32687/0869-866X-2022-30-s1-1038-1043</article-id><article-categories><subj-group subj-group-type="heading"><subject>Научная статья</subject></subj-group></article-categories><title-group><article-title>DIGITAL THERAPY TECHNOLOGIES (LITERATURE REVIEW)</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Kravchuk</surname><given-names>A. A.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Aksenova</surname><given-names>E. I.</given-names></name><bio></bio><email>-</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kamynina</surname><given-names>N. N.</given-names></name><bio></bio><email>kamyninann@zdrav.mos.ru</email><xref ref-type="aff" rid="aff-1"/><xref ref-type="aff" rid="aff-2"/></contrib></contrib-group><aff id="aff-1">Research Institute for Healthcare Organization and Medical Management of Moscow Healthcare Department</aff><aff id="aff-2">Peoples’ Friendship University of Russia</aff><pub-date date-type="epub" iso-8601-date="2022-11-15" publication-format="electronic"><day>15</day><month>11</month><year>2022</year></pub-date><volume>30</volume><issue>s1</issue><fpage>1038</fpage><lpage>1043</lpage><history><pub-date date-type="received" iso-8601-date="2022-11-17"><day>17</day><month>11</month><year>2022</year></pub-date></history><permissions><copyright-statement>Copyright © 2022,</copyright-statement><copyright-year>2022</copyright-year></permissions><abstract>This article presents an analysis of international experience in the implementation of digital therapeutics technologies in health care. The features of digital therapeutics products: their distinction from digital health products and digital medicine are highlighted. An analysis of the global market for digital therapeutics is presented. The aspects of regulation of digital therapeutics and the barriers to its implementation are presented. The importance of digital therapeutics for the transition of health systems to a value-based management model is discussed.</abstract><kwd-group xml:lang="en"><kwd>digital therapeutics</kwd><kwd>review</kwd><kwd>healthcare</kwd><kwd>medical technology</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>цифровая терапия</kwd><kwd>обзор</kwd><kwd>здравоохранение</kwd><kwd>медицинские технологии</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Goldsack J., Coder M., Fitzgerald C. et al. Digital Health, digital medicine, digital therapeutics (DTx): what’s the difference. URL: https://www.dimesociety.org/digital-health-digital-medicine-digital-therapeutics-dtx-whats-the-difference (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Будущее цифровых систем здравоохранения в Европейском регионе: oтчет о проведении симпозиума ВОЗ (Копенгаген, Дания, 6-8 февраля 2019 г.). URL: https://apps.who.int/iris/bitstream/handle/10665/330370/9789289059985-rus.pdf (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Dang A., Arora D., Rane P. Role of digital therapeutics and the changing future of healthcare //j. Family Med. Prim. Care. 2020. Vol. 9, N 5. P. 2207-2213. DOI: 10.4103/jfmpc.jfmpc_105_20</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Digital Therapeutics Market Forecast to 2028 - COVID-19 impact and global analysis by application and distribution channel. URL: https://www.researchandmarkets.com/research/k3bkcf/global_8_94_bn?w=12 (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Chung J. Y. Digital therapeutics and clinical pharmacology // Transl. Clin. Pharmacol. 2019. Vol. 27, N 1. P. 6-11. DOI: 10.12793/tcp.2019.27.1.6</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Advisory firm «MarketsandMarkets™ Research Private Ltd.». Digital therapeutics (DTx) market by application (prediabetes, nutrition, care, diabetes, CVD, CNS, CRD, MSD, GI, substance abuse, rehabilitation), sales channel (B2C, patient, caregiver, B2B, providers, payer, employer, pharma) (2022-2026). URL: https://www.marketsandmarkets.com/Market-Reports/digital-therapeutics-market-51646724.html (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Мarket intelligence and advisory firm «Mordor Intelligence». Digital therapeutic devices market - growth, trends, COVID-19 impact and forecasts (2022-2027). URL: https://www.mordorintelligence.com/ru/industry-reports/digital-therapeutic-devices-market (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Deloitte Touche Tohmatsu. Digital therapeutics catalysing the future of health. URL: https://www2.deloitte.com/content/dam/Deloitte/ch/Documents/life-sciences-health-care/deloitte-ch-en-lshc-digital-therapeutics.pdf (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Recchia G., Capuano D. M., Mistri N., Verna R. Digital therapeutics - what they are, what they will be // Acta Sci. Med. Sci. 2020. Vol. 4, N 3. P. 134-142. DOI: 10.31080/ASMS.2020.04.0575</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Digital Therapeutics Alliance. URL: http://dtxalliance.org (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Sverdlov О., van Dam J., Hannesdottir K., Thornton-Wells T. Therapeutics: an integral component of digital innovation in drug development // Clin. Pharmacol. Ther. 2018. Vol. 104, N 1. P. 72-80. DOI: 10.1002/cpt.1036</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Ларина О. Д., Орлова О. С., Дегтярева М. В. Цифровая терапия - инновационное направление логопедической работы // Специальное образование. 2021. № 3. C. 115-139.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Williams M. G., Stott R., Bromwich N. et al. Determinants of and barriers to adoption of digital therapeutics for mental health at scale in the NHS // BMJ Innovations. 2020. Vol. 6. P. 92-98. DOI: 10.1136/bmjinnov-2019-000384</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Research and advisory company of Allied Analytics LLP. Digital therapeutics market by application (diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others), product type (software, and devices), and sales channel (business-to-business and business-to-consumers): global opportunity analysis and industry forecast, 2021-2030. URL: https://www.alliedmarketresearch.com/digital-therapeutics-market (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>International Medical Device Regulators Forum. URL: https://www.imdrf.org/about (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Холовня-Волоскова М. Э., Толкушин А. Г., Корнилова Е. Б., Завьялов А. А. Сравнительная характеристика видов оценки медицинских технологий // Проблемы социальной гигиены, здравоохранения и истории медицины. 2020. Т. 28, № S2. С. 1168-1175. DOI: 10.32687/0869-866X-2020-28-s2-1168-1175</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Parcher B., Coder M. Decision makers need an approach to determine digital therapeutic product quality, access, and appropriate use //j. Manag. Care Spec. Pharm. 2021. Vol. 27, N 4. P. 536-538.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>The Growing Value of Digital Health. Parsipanny; 2017. P. 76. URL: https://regresearchnetwork.org/wp-content/uploads/the-growing-value-of-digital-health.pdf (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Grigolo S. et al. The patient, digital health and digital therapeutics // Tendenze nuove, Numero Speciale 4 2021; 161-178. URL: https://www.tendenzenuove.it/2021/07/29/the-patient-digital-health-and-digital-therapeutics (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hong J. S., Wasden C., Han D. H.Introduction of digital therapeutics // Comput. Methods Programs Biomed. 2021. Vol. 209. P. 106319. DOI: 10.1016/j.cmpb.2021.106319</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Lovett L. Digital therapeutics may not cause toxicity, but they’re not entirely without risk. URL: https://www.mobihealthnews.com/news/north-america/digital-therapeutics-may-not-cause-toxicity-theyre-not-entirely-without-risk (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Ковальский В. Цифровое здравоохранение - где в нем бизнес, а где мыльный пузырь? URL: https://www.forbes.ru/tehnologii/339101-cifrovoe-zdravoohranenie-gde-v-nem-biznes-gde-mylnyy-puzyr (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Joyce M., Leclerc O., Westhues K., Xue H. Digital therapeutics: рreparing for takeoff. URL: https://www.mckinsey.com/industries/life-sciences/our-insights/digital-therapeutics-preparing-for-takeoff (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Khirasaria R., Singh V., Batta A. Exploring digital therapeutics: the next paradigm of modern health-care industry // Perspect. Clin. Res. 2020. Vol. 11, N 2. P. 54-58. DOI: 10.4103/picr.PICR_89_19</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Rastegayeva I. The rise of digital therapeutics. URL: https://blogs.3ds.com/northamerica/the-rise-of-digital-therapeutics (дата обращения: 16.05.2022).</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Wiederhold B. K. Data-driven digital therapeutics: the path forward // Cyberpsychology, Behavior, and Social Networking. 2021. Vol. 24, N 10. P. 631-632. DOI: 10.1089/cyber.2021.29227.editorial</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Abbadessa G., Brigo F., Clerico M. et al. Digital therapeutics in neurology //j. Neurol. 2021. Vol. 269, N 13. P. 1-16. DOI: 10.1007/s00415-021-10608-4</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Ferguson C., Hickman L., Wright R. et al. Preparing nurses to be prescribers of digital therapeutics // Contemp. Nurse. 2018. Vol. 54, N 4-5. P. 345-349. DOI: 10.1080/10376178.2018.1486943</mixed-citation></ref></ref-list></back></article>
